Uma alternativa para o fortalecimento da inovação nas áreas farmacêutica e de biotecnologia no Brasil. / An alternative to reinforce the innovation in the pharmaceutical and biotechnological fields in Brazil.

AUTOR(ES)
DATA DE PUBLICAÇÃO

2009

RESUMO

The present work suggests alternatives in the pharma and biotechnology innovation areas to use the results of Brazilian inventions obtained in research institutes and biotechnology companies for the production of novel drugs. We present some suggestions to improve the Brazilian legal system based on legal structures and using examples of the American legal system as a reference. Thus, we suggested setting up specific purposes companies between the public and private sector to develop innovation, which would allow solving strategic questions, such as patent co-ownership, through corporate agreements (quotaholders or shareholders). In addition, we recommend the establishment of a technology innovation office in researches institutes, such as Instituto Butantan to allow it to be able to take advantages offered by the Brazilian innovation law and, along the lines of the Bayh Dole Act, duly in force in United States, we suggested that the public sector, when licensing its patents, grant privileges to small national companies.

ASSUNTO(S)

innovation pesquisador biotecnologia biotechnology pharmaceutical improvement researcher farmacêutica aprimoramento inovação

ACESSO AO ARTIGO

Documentos Relacionados